Multiple sclerosis and pregnancy: Experience from a nationwide database in Germany

Therapeutic Advances in Neurological Disorders

Volumn 5, Issue 5, 2012, Pages 247-253

  Hellwig, Kerstin ^a   Haghikia, Aiden ^b   Rockhoff, Milena ^b   Gold, Ralf ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

breastfeeding; disease modifying therapy (DMT); relapse rate

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER;

ADULT; ARTICLE; BIRTH; BREAST FEEDING; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MOTHER; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; RECURRENCE RISK;

EID: 84870428050     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285612453192     Document Type: Article

References (25)

1. Airas L. Jalkanen A. Alanen A. Pirttila T. Marttila R. (2010) Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 75: 474–476.
2. Amato M. Portaccio E. Ghezzi A. Hakiki B. Zipoli V. Martinelli V. et al. (2010) Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology 75: 1794–1802.
3. Boskovic R. Wide R. Wolpin J. Bauer D. Koren G. (2005) The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 65: 807–811.
4. Comi G. Filippi M. Wolinsky J. (2001) European / Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. European / Canadian Glatiramer Acetate Study Group. Ann Neurol 49: 290–297.
5. Confavreux C. Hutchinson M. Hours M. Cortinovis-Tourniaire P. Moreau T. (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285–291.
6. Coyle P. Christie S. Fodor P. Fuchs K. Giesser B. Gutierrez A. et al. (2004) Multiple sclerosis gender issues: clinical practices of women neurologists. Mult Scler 10: 582–588.
7. de Las Heras V. de Andres C. Tellez N. Tintore M. (2007) Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler 13: 981–984.
8. Fernandez Liguori N. Klajn D. Acion L. Caceres F. Calle A. Carra A. et al. (2009) Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study). Mult Scler 15: 555–562.
9. Gregg C. Shikar V. Larsen P. Mak G. Chojnacki A. Yong V. et al. (2007) White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27: 1812–1823.
10. Hellwig K. Beste C. Schimrigk S. Chan A. (2009 a) Immunomodulation and postpartum relapses in patients with multiple sclerosis. Ther Adv Neurol Disord 2: 7–11.
11. Hellwig K. Brune N. Haghikia A. Muller T. Schimrigk S. Schwodiauer V. et al. (2008) Reproductive counselling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand 118: 24–28.
12. Hellwig K. Gold R. (2011) Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis. J Neurol 258: 502–503.
13. Hellwig K. Haghikia A. Agne H. Beste C. Gold R. (2009 b) Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Arch Neurol 66: 1580–1581; author reply 1581.
14. Koch M. Uyttenboogaart M. Heersema D. Steen C. de Keyser J. (2009) Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psych 80: 676–678.
15. Langer-Gould A. Huang S. Gupta R. Leimpeter A. Greenwood E. Albers K. et al. (2009) Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 66: 958–963.
16. Li D. Paty D. (1999) Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. Ann Neurol 46: 197–206.
17. Lu E. Dahlgren L. Sadovnick A. Sayao A. Synnes A. Tremlett H. (2011) Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult Scler, in press.
18. McNeilly A. (2001) Lactational control of reproduction. Reprod Fertil Develop 13: 583–590.
19. Nelson L. Franklin G. Jones M. (1988) Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 259: 3441–3443.
20. Orton S. Herrera B. Yee I. Valdar W. Ramagopalan S. Sadovnick A. et al. (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5: 932–936.
21. Portaccio E. Ghezzi A. Hakiki B. Martinelli V. Moiola L. Patti F. et al. (2011) Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology, in press.
22. Ramagopalan S. Yee I. Byrnes J. Guimond C. Ebers G. Sadovnick D. (2012) Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry, in press.
23. Sandberg-Wollheim M. Alteri E. Moraga M. Kornmann G. (2011) Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler 17: 423–430.
24. Vukusic S. Hutchinson M. Hours M. Moreau T. Cortinovis-Tourniaire P. Adeleine P. et al. (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127: 1353–1360.
25. Weber-Schoendorfer C. Schaefer C. (2009) Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler 15: 1037–1042.